PATIENT ASSISTANCE PROGRAMS: BOON OR BOONDOGGLE?
PAPs valuable but increasingly ensnared in drug pricing predicament
By Marie Powers
Monday, October 17, 2016
"If you can't afford your medicine, Astrazeneca may be able to help." Millions of U.S. consumers hear and read those words every day in direct-to-consumer (DTC) ads from the London-based pharma and similar verbiage from its cohorts.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.